116 related articles for article (PubMed ID: 19885720)
1. Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study.
Magafa V; Borovicková L; Slaninová J; Cordopatis P
Amino Acids; 2010 May; 38(5):1549-59. PubMed ID: 19885720
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
[TBL] [Abstract][Full Text] [Related]
3. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
Flouret G; Chaloin O; Slaninová J
J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
[TBL] [Abstract][Full Text] [Related]
4. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
5. Analogues of oxytocin antagonists bearing a ureido group in the amino acid side chain at position 4 or 5.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 May; 12(5):347-53. PubMed ID: 16285023
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
[TBL] [Abstract][Full Text] [Related]
8. In position 7 L- and D-Tic-substituted oxytocin and deamino oxytocin: NMR study and conformational insights.
Spyranti Z; Fragiadaki M; Magafa V; Borovickova L; Spyroulias GA; Cordopatis P; Slaninova J
Amino Acids; 2010 Jul; 39(2):539-48. PubMed ID: 20108008
[TBL] [Abstract][Full Text] [Related]
9. Design of oxytocin antagonists, which are more selective than atosiban.
Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
[TBL] [Abstract][Full Text] [Related]
10. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
[TBL] [Abstract][Full Text] [Related]
11. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
12. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
[TBL] [Abstract][Full Text] [Related]
14. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
[TBL] [Abstract][Full Text] [Related]
15. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of oxytocin analogues containing L-alpha-t-butylglycine [Gly(Bu t)] in positions 8 or 9.
Fragiadaki M; Magafa V; Slaninová J; Cordopatis P
Peptides; 2003 Sep; 24(9):1425-31. PubMed ID: 14706558
[TBL] [Abstract][Full Text] [Related]
17. Enkephalin analogues containing beta-naphthylalanine at the fourth position.
Mierke DF; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1990 Jan; 29(1):179-96. PubMed ID: 2158358
[TBL] [Abstract][Full Text] [Related]
18. Magnesium and biological activity of oxytocin analogues modified on aromatic ring of amino acid in position 2.
Slaninová J; Maletínská L; Vondrásek J; Procházka Z
J Pept Sci; 2001 Aug; 7(8):413-24. PubMed ID: 11548057
[TBL] [Abstract][Full Text] [Related]
19. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
[TBL] [Abstract][Full Text] [Related]
20. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
